Workflow
Nuburu(BURU) - 2023 Q4 - Annual Report
BURUNuburu(BURU)2024-04-15 21:19

Financial Performance - The company reported a net loss of 20,706,384fortheyearendedDecember31,2023,comparedtoanetlossof20,706,384 for the year ended December 31, 2023, compared to a net loss of 14,129,101 for the previous year, representing a 46% increase in losses [351]. - Revenue for the year ended December 31, 2023, was 2,085,532,anincreaseof452,085,532, an increase of 45% compared to 1,440,428 in 2022 [364]. - Cost of revenue increased to 5,695,433in2023from5,695,433 in 2023 from 4,859,599 in 2022, resulting in a gross margin loss of 3,609,901[364].Totaloperatingexpensesrosesignificantlyto3,609,901 [364]. - Total operating expenses rose significantly to 18,225,819 in 2023, up from 10,578,618in2022,drivenbyincreasesinresearchanddevelopment,sellingandmarketing,andgeneralandadministrativeexpenses[364].ThenetlossfortheyearendedDecember31,2023,was10,578,618 in 2022, driven by increases in research and development, selling and marketing, and general and administrative expenses [364]. - The net loss for the year ended December 31, 2023, was 20,706,384, compared to a net loss of 14,129,101in2022,reflectingaworseningofapproximately4614,129,101 in 2022, reflecting a worsening of approximately 46% [364]. - The company reported a net loss per common share of 0.63 for 2023, an improvement from a loss of 2.59persharein2022[364].CashFlowandFinancingCashusedinoperatingactivitieswas2.59 per share in 2022 [364]. Cash Flow and Financing - Cash used in operating activities was 17,540,163 for 2023, up from 10,227,730in2022,indicatinga7210,227,730 in 2022, indicating a 72% increase in cash outflow [351]. - The company raised 9,225,000 from the issuance of Senior Convertible Notes and Warrants in June 2023, and 5,000,000fromJuniorNotesandWarrantsinNovember2023[351].Thecompanyreportedanetcashprovidedbyfinancingactivitiesof5,000,000 from Junior Notes and Warrants in November 2023 [351]. - The company reported a net cash provided by financing activities of 17,976,360 in 2023, compared to 7,636,447in2022,representinga1357,636,447 in 2022, representing a 135% increase [351]. - The company plans to finance operations through equity and debt financing, including a potential 100,000,000 from the Lincoln Park Purchase Agreement [351]. - Cash and cash equivalents at the end of the period were 2,148,700,downfrom2,148,700, down from 2,880,254 at the beginning of the period, a decrease of 26% [361]. Operational Efficiency and Cost Management - The company has initiated measures to improve operational efficiency and reduce costs, including temporary furloughs of employees, to align costs with anticipated near-term revenue [324]. - The company is implementing Six Sigma Lean methodologies to enhance manufacturing processes and reduce costs, aiming to improve product quality and decrease defects [327]. - The company anticipates requiring additional engineers and production personnel as manufacturing ramps up to meet customer demand [327]. - The company has incurred additional annual expenses as a public company, including costs related to directors' and officers' liability insurance and increased personnel costs [323]. Customer Dependence and Revenue Concentration - As of December 31, 2023, two customers accounted for 39% and 29% of the company's revenue, indicating a significant reliance on a small number of customers [336]. - The company has not experienced any collection issues with accounts receivable, indicating a stable financial position regarding customer payments [335]. - Revenue increased by 645,104duringtheyearendedDecember31,2023,drivenbya645,104 during the year ended December 31, 2023, driven by a 346,000 increase from additional shipments of BLTM-250 lasers and 296,000fromgovernmentcontracts[389].ResearchandDevelopmentResearchanddevelopmentexpensesincreasedto296,000 from government contracts [389]. Research and Development - Research and development expenses increased to 5,462,680 in 2023, up from 4,546,057in2022,indicatingafocusontechnologydevelopment[364].Thecompanyanticipatescontinuedinvestmentinresearchanddevelopmenttoenhanceexistingproductsanddevelopnewtechnologies[381].Researchanddevelopmentexpensesroseby4,546,057 in 2022, indicating a focus on technology development [364]. - The company anticipates continued investment in research and development to enhance existing products and develop new technologies [381]. - Research and development expenses rose by 916,623 in 2023, mainly due to an increase of approximately 1,600,000inpersonnelexpenses[389].MarketingandSalesSellingandmarketingexpensessurgedto1,600,000 in personnel expenses [389]. Marketing and Sales - Selling and marketing expenses surged to 1,539,690 in 2023, compared to 708,144in2022,highlightingincreasedeffortsinmarketoutreach[364].Sellingandmarketingexpensesincreasedby708,144 in 2022, highlighting increased efforts in market outreach [364]. - Selling and marketing expenses increased by 831,546 during the year ended December 31, 2023, attributed to higher personnel costs, including expenses related to a new Chief Marketing and Sales Officer [389]. Financial Position and Liabilities - The total current liabilities decreased from 14,590,504in2022to14,590,504 in 2022 to 10,028,688 in 2023, reflecting a reduction in financial obligations [341]. - The company has an accumulated deficit of 81,898,692asofDecember31,2023,comparedto81,898,692 as of December 31, 2023, compared to 61,192,308 at the end of 2022, reflecting a 34% increase in the deficit [362]. - Total current assets decreased to 4,293,509in2023from4,293,509 in 2023 from 8,485,401 in 2022, a decline of 49% [361]. Risks and Future Outlook - The company is subject to risks including rapid technological change and dependence on key individuals, which could materially affect future operating results [331]. - Future operations are subject to risks including the need for further technology development and securing long-term financing [368]. - The company expects to incur net losses for the foreseeable future while expanding operations and investing in manufacturing, sales, and marketing [391]. Internal Controls - No changes in internal control over financial reporting were reported [407]. - Management's report on internal controls over financial reporting was evaluated [405]. - No disagreements with accountants on accounting and financial disclosure were noted [409].